Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen

Author： Tornio Aleksi Niemi Mikko Neuvonen Pertti Backman Janne

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.63, Iss.5, 2007-05, pp. : 463-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone

By Tornio Aleksi Neuvonen Pertti Backman Janne

European Journal of Clinical Pharmacology, Vol. 62, Iss. 8, 2006-08 ,pp. : 645-651

Springer Publishing Company

Access to resources Recommend Favorite

Human CYP2C8: Structure, Substrate Specificity, Inhibitor Selectivity, Inducers and Polymorphisms

Current Drug Metabolism, Vol. 10, Iss. 9, 2009-11 ,pp. : 1009-1047

Bentham Science Publishers

Access to resources Recommend Favorite

Gemfibrozil/methotrexate/piperacillin/tazobactam interaction: Acute renal failure (first report of an interaction between methotrexate and gemfibrozil): 2 case reports

Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m‐hydroxymexiletine

Pharmacology Research & Perspectives, Vol. 3, Iss. 5, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

CYP2C8 and antimalaria drug efficacy

By Gil JP Gil Berglund E

Pharmacogenomics, Vol. 8, Iss. 2, 2007-02 ,pp. : 187-198

Future Medicine

Access to resources Recommend Favorite